Jacky Vonderscher
Fondateur chez ENYO Pharma SA
Profil
Jacky Vonderscher is the founder of ENYO Pharma SA, which was founded in 2014, where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer at Vonderscher & Co. Gmbh since 2013, Director at Lyonbiopôle, Member-Governors Board at The Innovative Medicines Initiative, and Independent Member-Supervisory Board at Step Pharma SAS.
Dr. Vonderscher's former positions include Independent Director at ObsEva SA from 2013 to 2021 and Senior Vice President at Hoffmann-La Roche Products Ltd.
from 2008 to 2013.
Dr. Vonderscher received a doctorate degree from the University of Geneva in 1986 and an undergraduate degree from Institut National des Sciences Appliquées de Toulouse in 1977.
Postes actifs de Jacky Vonderscher
| Sociétés | Poste | Début |
|---|---|---|
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Fondateur | 01/01/2014 |
| Vonderscher & Co. Gmbh | Directeur Général | 01/01/2013 |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Directeur/Membre du Conseil | - |
Lyonbiopôle
 Lyonbiopôle Miscellaneous Commercial ServicesCommercial Services Lyonbiopôle is a competitiveness cluster located in Lyon, France. The French company serves as a catalyst for the health innovation ecosystem by connecting, developing, and promoting it. Lyonbiopôle's main focus is on the health sector, and it works to ensure that the ecosystem is thriving and innovative. | Directeur/Membre du Conseil | - |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jacky Vonderscher
| Sociétés | Poste | Fin |
|---|---|---|
| OBSEVA SA | Directeur/Membre du Conseil | 19/11/2021 |
Hoffmann-La Roche Products Ltd.
 Hoffmann-La Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Products Ltd. develops and manufactures pharmaceuticals and diagnostic solutions. The company is based in Hamilton, Bermuda. | Corporate Officer/Principal | 01/12/2013 |
Formation de Jacky Vonderscher
| Institut National des Sciences Appliquées de Toulouse | Undergraduate Degree |
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OBSEVA SA | Health Technology |
| Entreprise privées | 6 |
|---|---|
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Health Technology |
| Vonderscher & Co. Gmbh | |
Hoffmann-La Roche Products Ltd.
Hoffmann-La Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Products Ltd. develops and manufactures pharmaceuticals and diagnostic solutions. The company is based in Hamilton, Bermuda. | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |
Lyonbiopôle
Lyonbiopôle Miscellaneous Commercial ServicesCommercial Services Lyonbiopôle is a competitiveness cluster located in Lyon, France. The French company serves as a catalyst for the health innovation ecosystem by connecting, developing, and promoting it. Lyonbiopôle's main focus is on the health sector, and it works to ensure that the ecosystem is thriving and innovative. | Commercial Services |
The Innovative Medicines Initiative
The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Retail Trade |